Objective To investigate the effect of self-made Guben Pingchuan Huatan decoction on curative effect and laboratory indexes of patients with chronic obstructive pulmonary disease .Methods 98 patients with chronic obstructive pulmonary disease (COPD) in stable stage in our hospital from September 2014 to September 2016 were selected and divided into observation group with 49 cases and control group with 49 cases according to the random number table method .The control group was given tiotropi-um bromide treatment ,while the observation group were given the basic treatment the same as the control group with the combina-tion of self-made Guben Pingchuan Huatan decoction .Two groups were treated for a period of 3 months .The therapeutic effects of the two groups were compared ,and the changes of pulmonary function ,6MWT and serum inflammatory factors before and after treatment were compared .Results The total effective rate in the observation group was higher than that in the control group (P<0 .05);FEV1 expected value ,PEF and FEV1/FVC value of the two groups after treatment were increased (P<0 .05);FEV1 expec-ted value ,PEF and FEV1/FVC value of the observation group were higher than those of the control group after treatment ,and the difference was statistically significant (P<0 .05);6MWT of two groups after treatment was increased (P<0 .05);6MWT of the observation group after treatment was higher than that of the control group ,and the difference was statistically significant (P<0 .05);IL-6 ,IL-8 and MMP-9 levels were decreased after treatment in two groups (P<0 .05);IL-6 ,IL-8 and MMP-9 levels of the observation group were lower than those of the control group ,and the difference was statistically significant (P<0 .05) .Conclusion The self-made Guben Pingchuan Huatan decoction has a remarkable curative effect on chronic obstructive pulmonary disease ,and can significantly improve the pulmonary function of patients ,and lower serum inflammatory cytokines IL-6 ,IL-8 and MMP-9 levels , thereby reducing the inflammatory state of patients .%目的 探讨自拟固本平喘化痰方对慢性阻塞性肺疾病稳定期疗效及实验室指标的影响.方法 选取该院于2014年9月至2016年9月收治的慢性阻塞性肺疾病稳定期患者98例,按照随机数字表法分为观察组49例与对照组49例.对照组给予噻托溴铵治疗,观察组在对照组基础上联合自拟固本平喘化痰方治疗.两组疗程均为3个月.比较两组治疗疗效,治疗前后肺功能、6 min步行距离(6MWT)及血清炎症因子水平变化.结果 观察组治疗总有效率高于对照组,比较差异有统计学意义(P<0.05);两组患者治疗后一秒用力呼气容积(FEV1)预计值、最大呼气流量(PEF)、FEV1/用力肺活量(FVC)增加,观察组患者治疗后FEV1预计值、PEF、FEV1/FVC高于对照组,比较差异有统计学意义(P<0.05);两组患者治疗后6MWT增加,观察组患者治疗后6MWT高于对照组,比较差异有统计学意义(P<0.05);两组患者治疗后IL-6、IL-8、MMP-9水平降低,观察组患者治疗后IL-6、IL-8、MMP-9水平低于对照组,比较差异有统计学意义(P<0.05).结论 自拟固本平喘化痰方对慢性阻塞性肺疾病稳定期疗效明显,且可明显改善患者肺功能,降低血清炎症因子IL-6、IL-8、M M P-9水平,从而减轻患者炎症状态.
展开▼
